EpiEP Inc., founded in the United States, is a medical device company dedicated to advancing cardiac healthcare solutions. The company's core mission is to innovate minimally invasive techniques for electrophysiology procedures. EpiEP's flagship product, the EpiAccess™ system, features an FDA-cleared and CE-marked pressure-guided needle designed to alert physicians of the needle tip location during epicardial access procedures. This technology aims to improve safety and efficacy in entering the pericardial space, addressing critical needs in cardiac treatment.
Notable figures affiliated with EpiEP include its team of experienced medical device engineers and healthcare professionals. The company has attracted significant attention from investors focused on medical innovations. Key achievements include the successful development and regulatory approval of the EpiAccess™ system, which has been recognized for its potential to revolutionize electrophysiology procedures. EpiEP's impact lies in its commitment to enhancing patient outcomes and setting new standards in cardiac care through cutting-edge technology.
